Brain zaps and probiotics: a new combo for IBS sufferers?

NCT ID NCT07172139

Not yet recruiting Symptom relief Sponsor: Rui Li Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether combining a non-invasive brain stimulation technique called rTMS with either a gut relaxant (pinaverium bromide) or a probiotic (bifidobacteria) can better ease symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D). About 140 adults with chronic abdominal pain and diarrhea will be randomly assigned to one of four treatment groups for two weeks. The goal is to see if the combination works better than either approach alone, with a focus on reducing pain and improving stool consistency.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

repetitive transcranial magnetic stimulation (rTMS), pinaverium bromide, and bifidobacterium probiotic

What this could lead to

If successful, this could point toward a new combination treatment that better relieves abdominal pain and diarrhea for people with IBS-D.

What could go wrong

This is an early-stage trial with only 140 participants, so results may not apply to everyone. The brain stimulation and medications may cause mild side effects like headache or digestive upset, and the sham group helps check if benefits are real.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••